Hasil Pencarian - Axel Bex

Perbaiki Hasil
  1. 1
    Partial Nephrectomy for Metastatic Renal Cell Carcinoma: Con

    Partial Nephrectomy for Metastatic Renal Cell Carcinoma: Con oleh Teele Kuusk, Axel Bex

    Diterbitkan 2022-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Cytoreductive Nephrectomy: Still Necessary in 2021

    Cytoreductive Nephrectomy: Still Necessary in 2021 oleh Arnaud Méjean, Axel Bex

    Diterbitkan 2022-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Open Science and Open Publishing: A New Paradigm for the European Urology Family

    Open Science and Open Publishing: A New Paradigm for the European Urology Family oleh Jochen Walz, Axel Bex, Guillaume Ploussard, Silvia Proietti, James Catto

    Diterbitkan 2020-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Cytoreductive nephrectomy in the current treatment algorithm

    Cytoreductive nephrectomy in the current treatment algorithm oleh Teele Kuusk, Bernadett Szabados, Wing Kin Liu, Thomas Powles, Axel Bex

    Diterbitkan 2019-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Outcomes for Atypical Tumor Recurrences Following Minimally Invasive Kidney Cancer Operations

    Outcomes for Atypical Tumor Recurrences Following Minimally Invasive Kidney Cancer Operations oleh Paul Russo, Kyle A. Blum, Stanley Weng, Niels Graafland, Axel Bex

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Multicenter randomized trial of deferred cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma receiving checkpoint inhibitors: the NORDIC-SUN-Trial

    Multicenter randomized trial of deferred cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma receiving checkpoint inhibitors: the NORDIC-SUN-Trial oleh Laura Iisager, Johanne Ahrenfeldt, Frede Donskov, Börje Ljungberg, Axel Bex, Lars Lund, Iben Lyskjær, Niels Fristrup

    Diterbitkan 2024-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    B2B: Kidney Cancer Summary

    B2B: Kidney Cancer Summary oleh Simon Tanguay, E. Jason Abel, Laurence Albigès, Toni Choueiri, Axel Bex, Umberto Capitanio, Maxine Tran, Alessandro Volpe, Peter Black

    Diterbitkan 2021-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Patient-reported Experience of Diagnosis, Management, and Burden of Renal Cell Carcinomas: Results from a Global Patient Survey in 43 Countries

    Patient-reported Experience of Diagnosis, Management, and Burden of Renal Cell Carcinomas: Results from a Global Patient Survey in 43 Countries oleh Rachel Giles, Deborah Maskens, Robert Bick, Robin Martinez, Malcolm Packer, Daniel Heng, James Larkin, Axel Bex, Michael Jewett, Eric Jonasch, Sara MacLennan

    Diterbitkan 2022-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Case Report: Disease progression of renal cell carcinoma containing a novel putative pathogenic KAT6A::NRG1 fusion on Ipilimumab- Nivolumab immunotherapy. A case study and review of the literature

    Case Report: Disease progression of renal cell carcinoma containing a novel putative pathogenic KAT6A::NRG1 fusion on Ipilimumab- Nivolumab immunotherapy. A case study and review o... oleh Almas Dawood, Suzanne MacMahon, My-Anh Tran Dang, Maxine G. B. Tran, Maxine G. B. Tran, Axel Bex, Ekaterini Boleti, Soha El Sheikh, Soha El Sheikh

    Diterbitkan 2023-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    A protocol for the development of core outcome sets for effectiveness trials and clinical audits in renal cell cancer (R‐COS)

    A protocol for the development of core outcome sets for effectiveness trials and clinical audits in renal cell cancer (R‐COS) oleh Steven MacLennan, Lisa M. Wintner, Katharina Beyer, Ailbhe Lawlor, Sheela Tripathee, Saeed Dabestani, Lorenzo Marconi, Rachel H. Giles, Rose Woodward, Mieke Van Hemelrijck, Axel Bex, Patricia Zondervan

    Diterbitkan 2023-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Sources of Frustration Among Patients Diagnosed With Renal Cell Carcinoma

    Sources of Frustration Among Patients Diagnosed With Renal Cell Carcinoma oleh Cristiane Decat Bergerot, Dena Battle, Paulo Gustavo Bergerot, Nazli Dizman, Eric Jonasch, Hans J. Hammers, Daniel J. George, Axel Bex, Borje Ljungberg, Sumanta Kumar Pal, Michael D. Staehler

    Diterbitkan 2019-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    A Systematic Review of Patient Race, Ethnicity, Socioeconomic Status, and Educational Attainment in Prostate Cancer Treatment Randomised Trials—Is the Evidence Base Applicable to the General Patient Population?

    A Systematic Review of Patient Race, Ethnicity, Socioeconomic Status, and Educational Attainment in Prostate Cancer Treatment Randomised Trials—Is the Evidence Base Applicable to t... oleh Siddhant Patki, Julian Aquilina, Rebecca Thorne, Isaac Aristidou, Filipe Brogueira Rodrigues, Hannah Warren, Axel Bex, Veeru Kasivisvanathan, Caroline Moore, Kurinchi Gurusamy, Mark Emberton, Lawrence M.J. Best, Maxine G.B. Tran

    Diterbitkan 2023-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    A Systematic Review of Heterogeneity in Outcome Definition and Reporting in Localised Renal Cancer

    A Systematic Review of Heterogeneity in Outcome Definition and Reporting in Localised Renal Cancer oleh Katharina Beyer, Christiaan Widdershoven, Lisa M. Wintner, Saeed Dabestani, Lorenzo Marconi, Charlotte Moss, Netty Kinsella, Yuhong Yuan, Rachel H. Giles, Ravi Barod, Mieke Van Hemelrijck, Axel Bex, Patricia Zondervan, Steven MacLennan

    Diterbitkan 2023-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    T cells expanded from renal cell carcinoma display tumor-specific CD137 expression but lack significant IFN-γ, TNF-α or IL-2 production

    T cells expanded from renal cell carcinoma display tumor-specific CD137 expression but lack significant IFN-γ, TNF-α or IL-2 production oleh Saskia D. van Asten, Rosa de Groot, Marleen M. van Loenen, Suzanne M. Castenmiller, Jeroen de Jong, Kim Monkhorst, John B.A.G. Haanen, Derk Amsen, Axel Bex, Robbert M. Spaapen, Monika C. Wolkers

    Diterbitkan 2021-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    The VENUSS prognostic model to predict disease recurrence following surgery for non-metastatic papillary renal cell carcinoma: development and evaluation using the ASSURE prospective clinical trial cohort

    The VENUSS prognostic model to predict disease recurrence following surgery for non-metastatic papillary renal cell carcinoma: development and evaluation using the ASSURE prospecti... oleh Tobias Klatte, Kevin M. Gallagher, Luca Afferi, Alessandro Volpe, Nils Kroeger, Silvia Ribback, Alan McNeill, Antony C. P. Riddick, James N. Armitage, Tevita F. ‘Aho, Tim Eisen, Kate Fife, Axel Bex, Allan J. Pantuck, Grant D. Stewart

    Diterbitkan 2019-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    An analysis of SPECT/CT non-visualization of sentinel lymph nodes in renal tumors

    An analysis of SPECT/CT non-visualization of sentinel lymph nodes in renal tumors oleh Teele Kuusk, Maarten L. Donswijk, Renato A. Valdés Olmos, Roderick E. De Bruijn, Oscar R. Brouwer, Kees Hendricksen, Simon Horenblas, Katarzyna Jóźwiak, Warner Prevoo, Henk G. Van Der Poel, Bas W. G. Van Rhijn, Esther M. Wit, Axel Bex

    Diterbitkan 2018-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    Indications and Outcomes for Deferred Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Combination Therapy: Can Systemic Therapy be Withdrawn in Patients with No Evidence of Disease?

    Indications and Outcomes for Deferred Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Combination Therapy: Can Systemic Therapy be Withdrawn in Patients with No Evi... oleh Elisabeth E. Fransen van de Putte, Luna van den Brink, Mohamed A. Mansour, Johannes C. van der Mijn, Sofie Wilgenhof, Johannes V. van Thienen, John B.A.G. Haanen, Ekaterini Boleti, Thomas Powles, Patricia J. Zondervan, Niels M. Graafland, Axel Bex

    Diterbitkan 2023-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    Centralisation of specialist cancer surgery services in two areas of England: the RESPECT-21 mixed-methods evaluation

    Centralisation of specialist cancer surgery services in two areas of England: the RESPECT-21 mixed-methods evaluation oleh Naomi J Fulop, Angus IG Ramsay, Cecilia Vindrola-Padros, Caroline S Clarke, Rachael Hunter, Georgia Black, Victoria J Wood, Mariya Melnychuk, Catherine Perry, Laura Vallejo-Torres, Pei Li Ng, Ravi Barod, Axel Bex, Ruth Boaden, Afsana Bhuiya, Veronica Brinton, Patrick Fahy, John Hines, Claire Levermore, Satish Maddineni, Muntzer M Mughal, Kathy Pritchard-Jones, John Sandell, David Shackley, Maxine Tran, Steve Morris

    Diterbitkan 2023-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    The PRO-RCC study: a long-term PROspective Renal Cell Carcinoma cohort in the Netherlands, providing an infrastructure for ‘Trial within Cohorts’ study designs

    The PRO-RCC study: a long-term PROspective Renal Cell Carcinoma cohort in the Netherlands, providing an infrastructure for ‘Trial within Cohorts’ study designs oleh Hilin Yildirim, Christiaan V Widdershoven, Maureen JB Aarts, Axel Bex, Haiko J Bloemendal, Deirdre M Bochove-Overgaauw, Paul Hamberg, Karin H Herbschleb, Tom van der Hulle, Brunolf W Lagerveld, Martijn GH van Oijen, Sjoukje F Oosting, Johannes V van Thienen, Astrid AM van der Veldt, Hans M Westgeest, Evelijn E Zeijdner, Katja KH Aben, Corina van den Hurk, Patricia J Zondervan, Adriaan D Bins

    Diterbitkan 2023-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    Major Urological Cancer Surgery for Patients is Safe and Surgical Training Should Be Encouraged During the COVID-19 Pandemic: A Multicentre Analysis of 30-day Outcomes

    Major Urological Cancer Surgery for Patients is Safe and Surgical Training Should Be Encouraged During the COVID-19 Pandemic: A Multicentre Analysis of 30-day Outcomes oleh Wei Shen Tan, Rajan Arianayagam, Pramit Khetrapal, Edward Rowe, Samantha Kearley, Ahmed Mahrous, Raj Pal, William Fowler, Rakesh Heer, Mohamed Elajnaf, Jayne Douglas-Moore, T.R. Leyshon Griffiths, James Voss, Daniel Wilby, Omar Al Kadhi, Jonathan Noel, Nikhil Vasdev, Alastair McKay, Imran Ahmad, Islam Abu-Nayla, Benjamin Lamb, George T. Hill, Krishna Narahari, Howard Kynaston, Arzu Yousuf, Venkata R.M. Kusuma, Jo Cresswell, Pete Cooke, Aniruddha Chakravarti, Ravi Barod, Axel Bex, John D. Kelly

    Diterbitkan 2021-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: